摘要
目的观察青娥丸治疗绝经后骨质疏松症的临床疗效。方法将55例患者随机分为3组,治疗组(A组)18例服用青娥丸治疗,对照组(B组)19例服用仙灵骨葆胶囊治疗,治疗组(C组)18例服用青娥丸+仙灵骨葆胶囊治疗,2个月为1个疗程,均为3个疗程,治疗结束后观察临床疗效及骨密度变化。结果经过3个疗程的治疗,治疗前后组间显效率、骨密度值均有统计学意义。结论青娥丸可明显改善绝经后骨质疏松患者的临床症状,同时能够提高骨密度。
Objective To observe the clinical therapeutic efficacy on prescription of Qing E Wan on Postmenopausal Osteoporosis. Methods According to the random number table,55 patients with Postmenopausal Osteoporosis were randomly divided into 3 groups. 18 patients in the treatment group-A were given Qing E Wan,19 patients in the control group-B were given Xian Ling Gu Bao Jiao Nang,while the other 18 patients in the treatment group-C were given Qing E Wan and Xian Ling Gu Bao Jiao Nang. The therapeutic course was six months in each group. We observed the clinical therapeutic efficacy and the change of bone mineral density. Results There was significant difference between before and after treatment. Conclusion The prescription of Qing E Wan was effective in improving the clinical symptoms and increasing the bone mineral density.
出处
《光明中医》
2015年第4期744-745,共2页
GUANGMING JOURNAL OF CHINESE MEDICINE
基金
国家自然科学基金(No.81373856)
关键词
青娥丸
绝经后骨质疏松症
临床疗效
骨密度
QingE Wan
Postmenopausal Osteoporosis
Clinical therapeutic efficacy
Bone mineral density
